Quantitative EEG analysis of executive dysfunction in Parkinson disease

Journal of Clinical Neurophysiology

Volumn 27, Issue 3, 2010, Pages 193-197

  Kamei, Satoshi ^a   Morita, Akihiko ^a   Serizawa, Kan ^a   Mizutani, Tomohiko ^a   Hirayanagi, Kaname ^b  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NIHON UNIVERSITY   (Japan)

Author keywords

Electrode location; Executive dysfunction; Multiple logistic regression analysis; Parkinson disease; Quantitative EEG

Indexed keywords

AGED; ALPHA RHYTHM; ARTICLE; BEHAVIORAL ASSESSMENT OF THE DYSEXECUTIVE SYNDROME; BETA RHYTHM; BRAIN REGION; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DELTA RHYTHM; ELECTRODE; ELECTROENCEPHALOGRAM; EXECUTIVE DYSFUNCTION; FRONTAL LOBE; HUMAN; OCCIPITAL LOBE; PARIETAL LOBE; PARKINSON DISEASE; PREDICTION; QUANTITATIVE ANALYSIS; SCORING SYSTEM; SLOW BRAIN WAVE; TEMPORAL LOBE; UNIFIED PARKINSON DISEASE RATING SCALE;

AGED; BRAIN MAPPING; COGNITION DISORDERS; ELECTRODES; ELECTROENCEPHALOGRAPHY; EXECUTIVE FUNCTION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LOGISTIC MODELS; MALE; MENTAL STATUS SCHEDULE; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE;

EID: 77953361631     PISSN: 07360258     EISSN: None     Source Type: Journal    
DOI: 10.1097/WNP.0b013e3181dd4fdb     Document Type: Article

References (42)

1. Braak H, Ghebremedhin E, Rüb U, et al. Stages in the development of Parkinson's disease-related pathology. Cell Tissue Res. 2004;318:121-134.
2. Caviness JN, Hentz JG, Evidente VG, et al. Both early and late cognitive dysfunction affects the electroencephalogram in Parkinson's disease. Parkinsonism Relat Disord. 2007;13:348-354.
3. Cheesman AL, Barker RA, Lewis SJ, et al. Lateralisation of striatal function: evidence from 18F-dopa PET in Parkinson's disease. J Neurol Neurosurg Psychiatry. 2005;76:1204-1210.
4. Chen KJ, Lin RT, Liu CK, et al. Relationship between event-related potentials and frontal-subcortical dysfunction in Parkinson's disease. Parkinsonism Relat Disord. 2006;12:453-458.
5. Cools R, Stefanova E, Barker RA, et al. Dopaminergic modulation of high-level cognition in Parkinson's disease: the role of the prefrontal cortex revealed by PET. Brain. 2002;125(pt 3):584-594.
6. Cooper JA, Sagar HJ, Jordan N, et al. Cognitive impairment in early, untreated Parkinson's disease and its relationship to motor disability. Brain. 1991;114: 2095-2122.
7. Downes JJ, Roberts AC, Sahakian BJ, et al. Impaired extra-dimensional shift performance in medicated and unmedicated Parkinson's disease: evidence for a specific attentional dysfunction. Neuropsychologia. 1989;27:1329-1343.
8. Emre M. Dementia associated with Parkinson's disease. Lancet Neurol. 2003;2: 229-237.
9. Emre M, Aarsland D, Brown R, et al. Clinical diagnostic criteria for dementia associated with Parkinson's disease. Mov Disord. 2007;22:1689-1707. (Pubitemid 47597592)
10. Fazekas F, Chawluk JB, Alavi A, et al. MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. AJR Am J Roentgenol. 1987;149: 351-356. (Pubitemid 17104996)
11. Foltynie T, Brayne CE, Robbins TW, Barker RA. The cognitive ability of an incident cohort of Parkinson's patients in the UK: the CamPaIGN study. Brain. 2004;127:550-560.
12. Geser F, Wenning GK, Poewe W, McKeith I. How to diagnose dementia with Lewy bodies: state of the art. Mov Disord. 2005;20(suppl 12):S11-S20.
13. Gibb WR, Lees AJ. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry. 1988;51: 745-752.
14. Hozumi A, Hirata K, Tanaka H, Yamazaki K. Perseveration for novel stimuli in Parkinson's disease: an evaluation based on event-related potentials topography. Mov Disord. 2000 15:835-842.
15. Kamei S, Tanaka N, Matsuura M, et al. Blinded, prospective, and serial evaluation by quantitative-EEG in interferon-alpha-treated hepatitis-C. Acta Neurol Scand. 1999;100:25-33.
16. Kamei S, Sakai T, Matsuura M, et al. Alterations of quantitative-EEG and minimental state examination in interferon-treated hepatitis C. Eur Neurol. 2002; 48:102-107.
17. Kamei S, Oga K, Matsuura M, et al. Correlation between quantitative-EEG alterations and age in patients with interferon-alpha-treated hepatitis C. J Clin Neurophysiol. 2005;22:49-52.
18. Kamei S, Hara M, Serizawa K, et al. Executive dysfunction using behavioral assessment of the dysexecutive syndrome in Parkinson's disease. Mov Disord. 2008;23:566-573.
19. Lees AJ, Smith E. Cognitive deficits in the early stages of Parkinson's disease. Brain. 1983;106:257-270.
20. Litvan I, Mohr E, Williams J, et al. Differential memory and executive functions in demented patients with Parkinson's and Alzheimer's disease. J Neurol Neurosurg Psychiatry. 1991;54:25-29.
21. McKeith IG, Galasko D, Kosaka K, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology. 1996;47:1113-1124.
22. Müller U, Wächter T, Barthel H, et al. Striatal [123I]-CIT SPECT and prefrontal cognitive functions in Parkinson's disease. J Neural Transm. 2000;107:303-319.
23. Neufeld MY, Inzelberg R, Korczyn AD. EEG in demented and non-demented parkinsonian patients. Acta Neurol Scand. 1988;78:1-5.
24. Neufeld MY, Blumen S, Aitkin I, et al. EEG frequency analysis in demented and nondemented parkinsonian patients. Dementia. 1994;5:23-28.
25. Owen AM, James M, Leigh PN, et al. Fronto-striatal cognitive deficits at different stages of Parkinson's disease. Brain. 1992;115:1727-1751.
26. Owen AM, Doyon J, Dagher A, et al. Abnormal basal ganglia outflow in Parkinson's disease identified with PET. Implications for higher cortical functions. Brain. 1998;121(pt 5):949-965.
27. Parkinson J. An essay on the shaking palsy. In: Critchley M, ed. James Parkinson, 1755-1824: A Bicentenary Volume of Papers Dealing with Parkinson's Disease. London, England: MacMillan Press. 1955:145-218.
28. Pezard L, Jech R, Ruzicka E. Investigation of non-linear properties of multichannel EEG in the early stages of Parkinson's disease. J Clin Neurophysiol. 2001;112:38-45.
29. Pillon B, Dubois B, Lhermitte F, Agid Y. Heterogeneity of cognitive impairment in progressive supranuclear palsy, Parkinson's disease, and Alzheimer's disease. Neurology. 1986;36:1179-1185.
30. Pillon B, Boller F, Levy R, et al. Cognitive deficits and dementia in Parkinson's disease. In: Boller F, Cappa S, eds. Handbook of Neuropsychology. 2nd ed., vol.6. Amsterdam: Elsevier 2001:311-371.
31. Primavera A, Novello P. Quantitative electroencephalography in Parkinson's disease, dementia, depression and normal aging. Neuropsychobiology. 1992; 25:102-105.
32. Serizawa K, Kamei S, Morita A, et al. Comparison of quantitative EEGs between Parkinson disease and age-adjusted normal controls. J Clin Neurophysiol. 2008;25:361-366.
33. Soikkeli R, Partanen J, Soininen H, et al. Slowing of EEG in Parkinson's disease. Electroencephalogr Clin Neurophysiol. 1991;79:159-165.
34. Tanaka H, Koenig T, Pascual-Marqui RD, et al. Event-related potential and EEG measures in Parkinson's disease without and with dementia. Dement Geriatr Cogn Disord. 2000;11:39-45.
35. Taylor AE, Saint-Cyr JA, Lang AE. Frontal lobe dysfunction in Parkinson's disease: the cortical focus of neostriatal outflow. Brain. 1986;109:845-883.
36. Tsuchiya H, Yamaguchi S, Kobayashi S. Impaired novelty detection and frontal lobe dysfunction in Parkinson's disease. Neuropsychologia. 2000;38:645-654.
37. Uekermann J, Daum I, Bielawski M, et al. Differential executive control impairments in early Parkinson's disease. J Neural Transm Suppl. 2004;68:39-51.
38. Van Sweden B, Wauquier A, Niedermeyer E. Normal ageing and transient cognitive disorders in the elderly. In: Niedermeyer E, Da Silva FL, eds. Electroencephalography: Basic Principles, Clinical Applications, and Related Fields. 4th ed. Baltimore, MD: Williams & Wilkins. 1999:340-348.
39. Wilson BA, Alderman N, Burgess PW, et al. Behavioural Assessment of the Dysexecutive Syndrome. Bury St. Edmunds, England: Thames Valley Test Company; 1996.
40. Yeager CL, Alberts WW, Delattre LD. Effect of stereotaxic surgery upon electroencephalographic status of parkinsonian patients. Neurology. 1966; 16:904-910.
41. Zijlmans JC, Pasman JW, Horstink MW, et al. EEG findings in patients with vascular parkinsonism. Acta Neurol Scand. 1998;98:243-247.
42. Zeng XH, Hirata K, Tanaka H, et al. Insufficient processing resources in Parkinson's disease: evaluation using multimodal event-related potentials paradigm. Brain Topogr. 2002 14:299-311.